跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Suboxone 2 mg/0.5 mg sublingual tablets - HSA Drug Approval Details
Approvals
/
HSA
/
Suboxone 2 mg/0.5 mg sublingual tablets
Approved
THERAPEUTIC
Suboxone 2 mg/0.5 mg sublingual tablets
RECKITT BENCKISER HEALTHCARE (UK) LTD
🇸🇬 Health Sciences Authority
Approval Date
Jan 28, 2008
Approval ID
0e6d0f3da178e1e6
Company
RECKITT BENCKISER HEALTHCARE (UK) LTD
Type
Therapeutic
Approval Details
Approval Id
0e6d0f3da178e1e6
Drug Name
Suboxone 2 mg/0.5 mg sublingual tablets
Product Name
Suboxone 2 mg/0.5 mg sublingual tablets
Approval Number
SIN13404P
Approval Date
2008-01-28
Registrant
ZUELLIG PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route Of Administration
SUBLINGUAL
Atc Code
N02AE01
Atc Item Name
buprenorphine
Pharma Manufacturer Name
ZUELLIG PHARMA PTE. LTD.
Company Detail Path
/organization/zuellig-pharma-pte-ltd
Active Ingredients
BUPRENORPHINE HCL
2.16MG
NALOXONE HCL
0.61MG
BUPRENORPHINE HCL
2.16MG
NALOXONE HCL
0.61MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 28, 2008
Approval ID
0e6d0f3da178e1e6
Type
Therapeutic
Back to HSA Approvals